Railroad, not sure about production yet, we'll know alot more after next shareholders meeting. I can only assume its ramping up based on a few things. 1. Orbimed deferred interest payments for two yrs. 2. Amgen production was slated to start this quarter. 3. Medimmune production started last quarter. 4. Management wants a rs now without filing for 6 month extension. Seems they are setting the stage for institutional/fund investors. Im curious as to the state of Abbvie/Sanofi/Hikma. Still a lot to find out.
News 
Market Data 
Discover 
